Related Experiment Video
Updated: Apr 27, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Tumor suppressing properties of rodent parvovirus NS1 proteins and their derivatives
Jürg P F Nüesch1, Jean Rommelaere
1Program "Infection and Cancer", Division Tumor Virology (F010), Deutsches Krebsforschungszentrum/German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, D-69120, Heidelberg, Germany, jpf.nuesch@dkfz-heidelberg.de.
Abstract:
Cancer chemotherapy with monospecific agents is often hampered by the rapid development of tumor resistance to the drug used. Therefore, combination treatments aiming at several different targets are sought. Viral regulatory proteins, modified or not, appear ideal for this purpose because of their multimodal killing action against neoplastically transformed cells. The large nonstructural protein NS1 of rodent parvoviruses is an excellent candidate for an anticancer agent, shown to interfere specifically with cancer cell growth and survival. The present review describes the structure, functions, and regulation of the multifunctional protein NS1, its specific interference with cell processes and cell protein activities, and what is known so far about the mechanisms underlying NS1 interference with cancer growth. It further outlines prospects for the development of new, multimodal cancer toxins and their potential applications.
Insights
Cancer treatment faces resistance. Viral proteins like NS1 show promise as multimodal anticancer agents, targeting cancer cells effectively by interfering with their growth and survival.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Cancer chemotherapy often fails due to drug resistance.
- Combination therapies targeting multiple pathways are needed.
- Viral proteins offer multimodal action against cancer cells.
Purpose of the Study:
- To review the structure, functions, and anticancer mechanisms of the NS1 protein from rodent parvoviruses.
- To explore the potential of NS1 as a novel anticancer agent.
- To discuss future prospects for developing NS1-based multimodal cancer toxins.
Main Methods:
- Literature review of studies on NS1 protein structure and function.
- Analysis of NS1's interactions with cellular processes and proteins.
- Examination of NS1's role in cancer cell growth and survival.
Main Results:
- The NS1 protein exhibits multifunctional properties.
- NS1 specifically interferes with cancer cell growth and survival mechanisms.
- Evidence suggests NS1's potential as an anticancer agent.
Conclusions:
- The NS1 protein is a promising candidate for developing novel, multimodal cancer therapies.
- Further research into NS1 mechanisms could lead to new therapeutic strategies.
- NS1-based toxins may overcome current chemotherapy resistance issues.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Abnormal Proliferation
Mechanisms of Retrovirus-induced Cancers
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

